1. Market Research
  2. > Manufacturing Market Trends
  3. > Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging

This BCC Research report provides an overview of the current and future global pharmaceutical contract manufacturing, research and packaging markets. The study includes estimates of sales figures for the five-year period through 2019.

Use this report to:
- Receive a detailed analysis of contract manufacturing, research and the packaging industry structure.
- Discuss the new developments and regulatory aspects in this industry.
- Receive information about the strategies for working with contract manufacturers, collaborations between companies and contract manufacturers, researchers and
packagers.
- Learn about the significant patents by category.

Highlights
- The global market for contract pharmaceutical manufacturing, research and packaging totaled $248.5 billion in 2014 and is projected to approach $352.8 billion by 2019, registering a compound annual growth rate (CAGR) of 7.3% through 2019.
- Contract manufacture of OTC and nutraceuticals as a segment totaled $138.7 billion in 2014 and should total $192.3 billion by 2019, with a CAGR of 6.8% for the period 2014-2019.
- Contract research as a segment reached $42.0 billion in 2014 and should reach $72.3 billion by 2019, with a CAGR of 11.5% between 2014 and 2019.

Introduction & Scope

INTRODUCTION

STUDY GOALS AND OBJECTIVES
Contract manufacturing companies offer services from research to manufacturing, including design, production and packaging. The rising burden created by patent
expiries of blockbuster drugs, stringent government regulations, increased competition, newer technologies and demand for channeling resources into core competencies are motivating and compelling factors for the growth of contract manufacturing. BCC Research’s goal in conducting this study is to provide an overview of the current and
future global market for contract manufacturing. The purpose is to present incisive analysis of the direction of contract manufacturing as an important instrument for
providing quality products in a cost-effective manner.

This report explores the present and future strategies of the players in the contract pharmaceutical market, which includes contract manufacturing, contract research and
contract packaging. A detailed analysis of contract manufacturing, research and the packaging industry structure has been conducted. Revenues are broken down by the
region. Sales figures are estimated for the five-year period from 2014 through 2019. The report also discusses the new developments and regulatory aspects in this industry. The report also covers significant patents by category.

REASONS FOR DOING THE STUDY
Many organizations have taken advantage of contract manufacturing, contract research and contract packaging in recent years. The companies involved in the contract process have greatly benefited from the alliance as it provides the manufacturing/research/packaging company with financial stability for the duration of the contract, while the hiring company benefits by saving costs and eliminating the stresses related to operating and managing a production facility and related research. This report also covers strategies for working with contract manufacturers, collaborations between companies and contract manufacturers, researchers and packagers, and mergers and acquisitions in the industry are also covered in this report. The demand for drugs coming to market at a faster pace, along with advances in treatments and changing technologies, are all factors influencing the market’s growth in the foreseeable future. This study looks at almost all the systems and processes affected by these factors.

INTENDED AUDIENCE
This study will be of interest to contract manufacturers, contract research and contract packaging organizations and the companies that use their services. Pharmaceutical,
biotechnical companies, research institutes and companies involved in the packaging of pharma and biotech products will also find this study to be of interest.

SCOPE OF REPORT
The scope of this study covers in-depth analysis of the global contract manufacturing, research and packaging markets. The contract manufacturing market for the pharmaceutical industry is segmented into various dosage forms, over-the-counter (OTC) and nutraceuticals, and drug delivery technologies. Clinical, drug discovery, analytical and other segments of pharmaceutical research through outsourcing have been analyzed under the contract research market. The contract packaging market is
segmented into primary, secondary and tertiary packaging. In the primary packaging market, primary containers are categorized as blisters, bottles and a large category of
“others,” which includes prefillable syringes, inhalers, vials and ampoules, caps and closures, dosing droppers, and labels and accessories. Analysis of market segments,
trends and revenue forecasts for the global, North American and European regions as well as emerging markets have been provided in detail. The emerging market for
contract manufacturing includes countries such as India, China, Japan, Korea, Taiwan, Canada, Africa, Australia, New Zealand, etc. BCC Research analyzes each market by its
application, its regulatory environment and its technology. This analysis includes market projections and estimating market shares of the players.

METHODOLOGY AND INFORMATION SOURCES
Both primary and secondary research methodologies were used in preparing this study. BCC Research conducted a comprehensive search of literature, which included
technical newsletters and journals, company and product literature, databases, indexes, abstracts and current financial, trade and government sources. Data were collected
through interviews and correspondence with contract manufacturers/packagers and research organizations. Projections were based on estimates such as the current
number of end users, potential end users, mergers and acquisitions, and market trends.

Table Of Contents

Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging
TABLE OF CONTENTS
CHAPTER 1 INTRODUCTION 2
STUDY GOALS AND OBJECTIVES 2
REASONS FOR DOING THE STUDY 2
INTENDED AUDIENCE 2
SCOPE OF REPORT 3
METHODOLOGY AND INFORMATION SOURCES 3
ANALYST'S CREDENTIALS 3
RELATED BCC RESEARCH REPORTS 4
BCC RESEARCH WEBSITE 4
DISCLAIMER 4
CHAPTER 2 EXECUTIVE SUMMARY 6
SUMMARY TABLE GLOBAL MARKET FOR CONTRACT PHARMACEUTICAL
MANUFACTURING, RESEARCH AND PACKAGING BY SEGMENT, THROUGH 2019 ($
BILLIONS)
7
SUMMARY FIGURE GLOBAL MARKET FOR CONTRACT PHARMACEUTICAL
MANUFACTURING, RESEARCH AND PACKAGING BY SEGMENT, 2012-2019 ($
BILLIONS)
7
CHAPTER 3 OVERVIEW 10
OUTSOURCING 10
HISTORY OF OUTSOURCING 10
TABLE 1 KEY DEVELOPMENTS IN THE HISTORY OF OUTSOURCING 11
KEY COMPONENTS OF A SUCCESSFUL OUTSOURCING STRATEGY 13
CORE FUNCTIONAL AREAS THAT NEED CONSTANT MONITORING 13
Cost Management 13
Communication Management 14
Performance Management 14
Risk Management 14
Crisis Management 14
Knowledge Transfer Management 14
Relationship Management 14
CONTRACT MANUFACTURING 15
TYPES OF CONTRACT MANUFACTURERS 15
Those Who "Supply" 15
Those Who "Toll" 15
Types of Toll Manufacturers 16
Sellers of Excess Capacity 16
Suitable Service Providers 16
Academic Institutions 16
FOUR STAGES OF CONTRACT MANUFACTURING 16
Program Initiation 16
Service Implementation 17
Final Agreement 17
Program Closure 17
CORE CAPABILITIES OF CMOS 17
REASONS FOR PHARMACEUTICAL CONTRACT MANUFACTURING 18
Reduce and Control Operating Costs 18
Focus on Core Competencies 18
Access to Advanced Technologies 18
Risk Sharing 18
BENEFITS OF CONTRACT MANUFACTURING 19
SUCCESS FACTORS IN CONTRACT MANUFACTURING 19
Product Quality 20
Cost-Competitiveness 20
Delivery Schedule 20
CM/Customer Relationship 20
RISKS IN CONTRACT MANUFACTURING 20
Lack of Control 20
Relationships 20
Quality Concerns 21
Intellectual Property Loss 21
Other Risks 21
Capacity Constraints 21
Loss of Flexibility and Responsiveness 21
TABLE 2 ADVANTAGES AND DISADVANTAGES OF CONTRACT MANUFACTURING 21
SYSTEMIC APPROACH FOR SELECTING A CONTRACT MANUFACTURER 22
Getting the List 23
Make a List 23
Contact CMOs and Create Request for Quote Package 23
Site Visit 23
Negotiation with the Finalists 24
CONTRACT RESEARCH ORGANIZATIONS 24
SERVICES OFFERED BY A CRO 24
BENEFITS OF USING A CRO 25
SELECTING A CRO 25
CLIENT-CRO RELATIONSHIP 26
KEYS FOR A SUCCESSFUL CLIENT-CRO RELATIONSHIP 27
Selecting the Right Partner 27
Avoiding Unclear Expectations and Vague or Conflicting
Requirements 27
Avoiding Micro-managing Every Step 27
Setting Realistic Expectations 27
Vendor's Input 28
Expecting a CRO to Replicate Client's Processes 28
Promising Based on Capabilities 28
Understanding the Project's Goals 28
Managing Communications 28
Problem-solving Aptitude 28
CONTRACT PACKAGING 29
TYPES OF PACKAGING 29
Primary Packaging 29
Secondary Packaging 29
Tertiary Packaging 30
REASONS A CONTRACT PACKAGER MIGHT BE NEEDED 30
CHOOSING A CONTRACT PACKAGER 31
Location 31
Relevant Experience 31
Ethics 31
Cost 31
Communication 31
Controls 31
Quality 32
ETHICAL STANDARDS FOR CONTRACT PACKAGERS 32
CHAPTER 4 REGULATORY ASPECTS 34
WARNING LETTERS 35
TABLE 3 PHARMACEUTICAL MANUFACTURERS THAT RECEIVED WARNING LETTERS,
2014 36
TABLE 4 PHARMACEUTICAL MANUFACTURERS THAT RECEIVED WARNING LETTERS,
2013 37
TABLE 5 PHARMACEUTICAL MANUFACTURERS THAT RECEIVED WARNING LETTERS,
2012 38
TABLE 6 PHARMACEUTICAL MANUFACTURERS THAT RECEIVED WARNING LETTERS,
2011 39
REGULATORY APPROVALS 39
TABLE 7 REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND
FACILITIES, 2014 40
TABLE 8 REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND
FACILITIES, 2013 41
TABLE 9 REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND
FACILITIES, 2012 41
TABLE 10 REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND
FACILITIES, 2011 42
CHAPTER 5 NEW DEVELOPMENTS 44
ACTAVIS PLC 44
LONZA 44
BRISTOL-MYERS SQUIBB 46
ABBVIE 47
ALBANY MOLECULAR RESEARCH INC. 48
BASF 49
EVOTEC AG 50
HOSPIRA 52
MALLINCKRODT 52
DR. REDDY'S LABORATORIES 52
PERRIGO CO. PLC 53
PATHEON 54
OTHER 54
CHAPTER 6 MARKET ANALYSIS: CONTRACT MANUFACTURING 58
CONTRACT MANUFACTURING OF BULK DRUGS/APIS 58
MARKET OVERVIEW 59
MARKET REVENUE 61
TABLE 11 GLOBAL REVENUE FOR BULK DRUG/APIS THROUGH CONTRACT
MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS) 61
FIGURE 1 GLOBAL REVENUE FOR BULK DRUG/APIS THROUGH CONTRACT
MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS) 62
CONTRACT MANUFACTURE OF DOSAGE FORMS 62
MARKET BY TYPE 63
Market Overview 64
Market Revenue 64
TABLE 12 GLOBAL REVENUE FOR CONTRACT MANUFACTURING OF VARIOUS
DOSAGE FORMS, THROUGH 2019 ($ MILLIONS) 65
FIGURE 2 GLOBAL REVENUE FOR CONTRACT MANUFACTURING OF VARIOUS
DOSAGE FORMS, 2012-2019 ($ MILLIONS) 65
MARKET BY REGION 66
Solid Dosage Form 66
Market Overview 66
Market Revenue 67
TABLE 13 GLOBAL REVENUE FOR SOLID DOSAGE FORMS THROUGH CONTRACT
MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS) 68
FIGURE 3 GLOBAL REVENUE FOR SOLID DOSAGE FORMS THROUGH CONTRACT
MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS) 68
Liquid Dosage Forms 68
Market Overview 69
Non-sterile Formulations 70
Sterile Formulations 71
Market Revenue for Non-sterile Formulations 71
TABLE 14 GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (NON-STERILE)
THROUGH CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS) 72
FIGURE 4 GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (NON-STERILE)
THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS) 72
Market Revenue for Sterile Formulations 73
TABLE 15 GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (STERILE) THROUGH
CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS) 73
FIGURE 5 GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (STERILE) THROUGH
CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS) 73
Semisolid Dosage Forms 74
Market Overview 74
Market Revenue 75
TABLE 16 GLOBAL REVENUE FOR SEMISOLID DOSAGE FORMS THROUGH
CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS) 76
FIGURE 6 GLOBAL REVENUE FOR SEMISOLID DOSAGE FORMS THROUGH
CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS) 76
MARKET BY FORMULATIONS 76
Solid Dosage Forms 77
Market Revenue for Solid Dosage Forms 77
TABLE 17 GLOBAL REVENUE FOR SOLID DOSAGE FORMS THROUGH CONTRACT
MANUFACTURING BY FORMULATION, THROUGH 2019 ($ MILLIONS) 78
FIGURE 7 GLOBAL REVENUE FOR SOLID DOSAGE FORMS THROUGH CONTRACT
MANUFACTURING BY FORMULATION, 2012-2019 ($ MILLIONS) 78
Market Share of Solid Dosage Formulations 78
TABLE 18 GLOBAL MARKET SHARE OF SOLID DOSAGE FORMS THROUGH
CONTRACT MANUFACTURING BY FORMULATION, 2013 (%) 78
FIGURE 8 GLOBAL MARKET SHARE OF SOLID DOSAGE FORMS THROUGH
CONTRACT MANUFACTURING BY FORMULATION, 2013 (%) 79
Liquid Dosage Forms 79
Market Revenue of Non-sterile Forms 80
TABLE 19 GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (NON-STERILE)
THROUGH CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($
MILLIONS)
80
FIGURE 9 GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (NON-STERILE)
THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($
MILLIONS)
81
Market Share of Non-sterile Formulations 81
TABLE 20 GLOBAL MARKET SHARE OF LIQUID DOSAGE FORMS (NON-STERILE)
THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%) 81
FIGURE 10 GLOBAL MARKET SHARE OF LIQUID DOSAGE FORMS (NON-STERILE)
THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%) 82
Market Revenue for Sterile Formulations 82
TABLE 21 GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (STERILE) THROUGH
CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($ MILLIONS) 83
FIGURE 11 GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (STERILE) THROUGH
CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($ MILLIONS) 83
Market Share of Sterile Formulations 84
TABLE 22 GLOBAL MARKET SHARE OF LIQUID DOSAGE FORMS (STERILE)
THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%) 84
FIGURE 12 GLOBAL MARKET SHARE OF LIQUID DOSAGE FORMS (STERILE)
THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%) 84
Semisolid Dosage Forms 84
Market Revenue 85
TABLE 23 GLOBAL REVENUE FOR SEMISOLID DOSAGE FORMS THROUGH
CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($ MILLIONS) 86
FIGURE 13 GLOBAL REVENUE FOR SEMISOLID DOSAGE FORMS THROUGH
CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($ MILLIONS) 86
Market Share 86
TABLE 24 GLOBAL MARKET SHARE OF SEMISOLID DOSAGE FORMS THROUGH
CONTRACT MANUFACTURING BY FORMULATION, 2013 (%) 87
FIGURE 14 GLOBAL MARKET SHARE OF SEMISOLID DOSAGE FORMS THROUGH
CONTRACT MANUFACTURING BY FORMULATION, 2013 (%) 87
ADVANCED DRUG DELIVERY PRODUCTS THROUGH CONTRACT
MANUFACTURING 87
MARKET OVERVIEW 88
TABLE 25 SOME CONTRACTING COMPANIES PROVIDING DRUG-DELIVERY SYSTEMS 90
MARKET BY REGION 91
TABLE 26 GLOBAL REVENUE FOR ADVANCED DRUG DELIVERY SYSTEMS THROUGH
CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS) 91
FIGURE 15 GLOBAL REVENUE FOR ADVANCED DRUG DELIVERY SYSTEMS
THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS) 91
MARKET BY FORMULATION 92
TABLE 27 GLOBAL REVENUE FOR ADVANCED DRUG DELIVERY SYSTEMS THROUGH
CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($ MILLIONS) 93
FIGURE 16 GLOBAL REVENUE FOR ADVANCED DRUG DELIVERY SYSTEMS
THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($
MILLIONS)
93
MARKET SHARE 94
TABLE 28 GLOBAL MARKET SHARE OF ADVANCED DRUG DELIVERY SYSTEMS
THROUGH CONTRACT MANUFACTURING BY TYPE, 2013 (%) 94
FIGURE 17 GLOBAL MARKET SHARE OF ADVANCED DRUG DELIVERY SYSTEMS
THROUGH CONTRACT MANUFACTURING BY TYPE, 2013 (%) 95
CONTRACT MANUFACTURE OF OTC AND NUTRACEUTICALS 95
MARKET BY REGION 95
Market Revenue 97
TABLE 29 GLOBAL REVENUE FOR OTC AND NUTRACEUTICALS THROUGH
CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ BILLIONS) 97
FIGURE 18 GLOBAL REVENUE FOR OTC AND NUTRACEUTICALS THROUGH
CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ BILLIONS) 98
MARKET BY FORMULATION 98
TABLE 30 GLOBAL REVENUE FOR OTC AND NUTRACEUTICALS THROUGH
CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($ BILLIONS) 99
FIGURE 19 GLOBAL REVENUE FOR OTC AND NUTRACEUTICALS THROUGH
CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($ BILLIONS) 99
Market Share 99
TABLE 31 GLOBAL MARKET SHARE OF OTC AND NUTRACEUTICALS THROUGH
CONTRACT MANUFACTURING BY FORMULATION, 2013 (%) 99
FIGURE 20 GLOBAL MARKET SHARE OF OTC AND NUTRACEUTICALS THROUGH
CONTRACT MANUFACTURING BY DOSAGE TYPE, 2013 (%) 100
CONTRACT MANUFACTURING OF BULK DRUGS AND DOSAGE FORMS BY
APPLICATION/THERAPEUTIC AREA 100
CARDIOVASCULARS 100
ANTIBIOTICS 101
ANALGESICS 102
ONCOLOGY 102
ANTIVIRALS 103
REPRODUCTIVE DRUG PRODUCTS 104
OTHER DRUGS 105
MARKET REVENUE 105
TABLE 32 GLOBAL REVENUE FOR CONTRACT MANUFACTURING DRUGS BY
THERAPEUTIC CATEGORY, THROUGH 2019 ($ MILLIONS) 106
FIGURE 21 GLOBAL REVENUE FOR CONTRACT MANUFACTURING DRUGS BY
THERAPEUTIC CATEGORY, 2012-2019 ($ MILLIONS) 106
MARKET SHARE 107
TABLE 33 GLOBAL MARKET SHARE OF VARIOUS THERAPEUTIC CATEGORIES IN
CONTRACT MANUFACTURING, 2013 (%) 107
FIGURE 22 GLOBAL MARKET SHARE OF VARIOUS THERAPEUTIC CATEGORIES IN
CONTRACT MANUFACTURING, 2013 (%) 107
CHAPTER 7 MARKET ANALYSIS: CONTRACT RESEARCH 109
MARKET BY DISCIPLINE 109
MARKET OVERVIEW 110
MARKET REVENUE 112
TABLE 34 GLOBAL REVENUE FOR CONTRACT RESEARCH BY DISCIPLINE, THROUGH
2019 ($ MILLIONS) 113
FIGURE 23 GLOBAL REVENUE FOR CONTRACT RESEARCH BY DISCIPLINE,
2012-2019 ($ MILLIONS) 113
MARKET SHARE 113
TABLE 35 GLOBAL MARKET SHARE OF CONTRACT RESEARCH BY DISCIPLINE, 2013
(%) 113
FIGURE 24 GLOBAL MARKET SHARE OF CONTRACT RESEARCH BY DISCIPLINE, 2013
(%) 114
MARKET BY REGION 114
MARKET OVERVIEW 115
MARKET REVENUE 116
TABLE 36 GLOBAL REVENUE FOR CONTRACT RESEARCH BY REGION, THROUGH
2019 ($ MILLIONS) 117
FIGURE 25 GLOBAL REVENUE FOR CONTRACT RESEARCH MARKET BY REGION,
2012-2019 ($ MILLIONS) 117
MARKET SHARE 117
TABLE 37 GLOBAL MARKET SHARE OF CONTRACT RESEARCH BY REGION, 2013 (%) 117
FIGURE 26 GLOBAL MARKET SHARE OF CONTRACT RESEARCH MARKET BY REGION,
2013 (%) 118
CONTRACT CLINICAL RESEARCH MARKET BY REGION 118
TABLE 38 GLOBAL REVENUE FOR CONTRACT CLINICAL RESEARCH BY REGION,
THROUGH 2019 ($ MILLIONS) 119
FIGURE 27 GLOBAL REVENUE FOR CONTRACT CLINICAL RESEARCH BY REGION,
2012-2019 ($ MILLIONS) 120
CONTRACT DRUG DISCOVERY MARKET BY REGION 120
TABLE 39 GLOBAL REVENUE FOR CONTRACT DRUG DISCOVERY BY REGION,
THROUGH 2019 ($ MILLIONS) 121
FIGURE 28 GLOBAL REVENUE FOR CONTRACT DRUG DISCOVERY BY REGION,
2012-2019 ($ MILLIONS) 121
CONTRACT ANALYTICAL RESEARCH MARKET BY REGION 122
TABLE 40 GLOBAL REVENUE FOR CONTRACT ANALYTICAL RESEARCH MARKET BY
REGION, THROUGH 2019 ($ MILLIONS) 123
FIGURE 29 GLOBAL REVENUE FOR CONTRACT ANALYTICAL RESEARCH MARKET BY
REGION, 2012-2019 ($ MILLIONS) 124
OTHER CONTRACT RESEARCH ACTIVITIES MARKET BY REGION 124
TABLE 41 GLOBAL REVENUE FOR OTHER CONTRACT RESEARCH MARKET BY
REGION, THROUGH 2019 ($ MILLIONS) 125
FIGURE 30 GLOBAL REVENUE FOR OTHER CONTRACT RESEARCH MARKET BY
REGION, 2012-2019 ($ MILLIONS) 125
MARKET BY THERAPEUTIC AREA 125
CARDIOLOGY 126
ONCOLOGY 127
INFLAMMATION AND IMMUNOLOGY 127
NEUROSCIENCE 128
VACCINES 129
OTHERS 130
MARKET REVENUE 131
TABLE 42 GLOBAL REVENUE FOR CONTRACT RESEARCH BY THERAPEUTIC AREA,
THROUGH 2019 ($ MILLIONS) 132
FIGURE 31 GLOBAL REVENUE FOR CONTRACT RESEARCH BY THERAPEUTIC AREA,
2012-2019 ($ MILLIONS) 132
MARKET SHARE 133
TABLE 43 GLOBAL MARKET SHARE OF CONTRACT RESEARCH BY THERAPEUTIC
AREA, 2013 (%) 133
FIGURE 32 GLOBAL MARKET SHARE OF CONTRACT RESEARCH BY THERAPEUTIC
AREA, 2013 (%) 133
CHAPTER 8 MARKET ANALYSIS: CONTRACT PACKAGING 135
MARKET BY TYPE 135
MARKET OVERVIEW 136
MARKET REVENUE 137
TABLE 44 GLOBAL REVENUE OF CONTRACT PACKAGING BY TYPE, THROUGH 2019
($ MILLIONS) 137
FIGURE 33 GLOBAL REVENUE OF CONTRACT PACKAGING BY TYPE, 2012-2019 ($
MILLIONS) 138
PRIMARY CONTAINERS BY TYPE 138
TABLE 45 GLOBAL REVENUE OF PRIMARY PACKAGING BY TYPE, THROUGH 2019 ($
MILLIONS) 139
FIGURE 34 GLOBAL REVENUE OF PRIMARY PACKAGING BY TYPE, 2012-2019 ($
MILLIONS) 139
MARKET SHARE 140
TABLE 46 GLOBAL MARKET SHARE OF CONTRACT PACKAGING BY TYPE, 2013 (%) 140
FIGURE 35 GLOBAL MARKET SHARE OF CONTRACT PACKAGING BY TYPE, 2013 (%) 140
MARKET BY REGION 141
MARKET OVERVIEW 141
MARKET REVENUE 143
TABLE 47 GLOBAL REVENUE OF CONTRACT PACKAGING BY REGION, THROUGH
2019 ($ MILLIONS) 143
FIGURE 36 GLOBAL REVENUE OF CONTRACT PACKAGING BY REGION, 2012-2019
($ MILLIONS) 143
MARKET SHARE 144
TABLE 48 GLOBAL MARKET SHARE OF CONTRACT PACKAGING BY REGION, 2013
(%) 144
FIGURE 37 GLOBAL MARKET SHARE OF CONTRACT PACKAGING BY REGION, 2013
(%) 144
PRIMARY PACKAGING BY REGION 145
TABLE 49 GLOBAL REVENUE FOR PRIMARY PACKAGING BY REGION, THROUGH
2019 ($ MILLIONS) 146
FIGURE 38 GLOBAL REVENUE FOR PRIMARY PACKAGING BY REGION, 2012-2019 ($
MILLIONS) 146
SECONDARY PACKAGING BY REGION 147
TABLE 50 GLOBAL REVENUE FOR SECONDARY PACKAGING BY REGION, THROUGH
2019 ($ MILLIONS) 148
FIGURE 39 GLOBAL REVENUE FOR SECONDARY PACKAGING BY REGION,
2012-2019 ($ MILLIONS) 148
OTHER TYPES OF PACKAGING BY REGION 149
TABLE 51 GLOBAL REVENUE FOR OTHER PACKAGING BY REGION, THROUGH 2019
($ MILLIONS) 150
FIGURE 40 GLOBAL REVENUE FOR OTHER PACKAGING BY REGION, 2012-2019 ($
MILLIONS) 150
CHAPTER 9 INDUSTRY STRUCTURE 152
CONTRACT MANUFACTURING 152
MARKET LEADERS 152
TABLE 52 SERVICES PROVIDED BY CONTRACT MANUFACTURING FIRMS 152
MARKET SHARES 153
Bulk Drugs and APIS 154
TABLE 53 GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING BULK DRUGS/APIs, 2013 (%) 154
FIGURE 41 GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING BULK DRUGS/APIs, 2013 (%) 154
Solid-Dosage Forms 155
TABLE 54 GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING SOLID DOSAGE FORMS, 2013 (%) 155
FIGURE 42 GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING SOLID DOSAGE FORMS, 2013 (%) 155
Liquid Dosage Forms 156
Non-sterile 156
TABLE 55 GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING LIQUID (NON-STERILE) DOSAGE FORMS, 2013 (%) 156
FIGURE 43 GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING LIQUID (NON-STERILE) DOSAGE FORMS, 2013 (%) 157
Sterile 158
TABLE 56 GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING LIQUID (STERILE) DOSAGE FORMS, 2013 (%) 158
FIGURE 44 GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING LIQUID (STERILE) DOSAGE FORMS, 2013 (%) 158
Semisolid Dosage Forms 159
TABLE 57 GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING SEMISOLID DOSAGE FORMS, 2013 (%) 159
FIGURE 45 GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES
PROVIDING SEMISOLID DOSAGE FORMS, 2013 (%) 160
CONTRACT RESEARCH 160
MARKET LEADERS 160
TABLE 58 SERVICES PROVIDED BY CONTRACT RESEARCH FIRMS 161
Market Shares 162
TABLE 59 GLOBAL MARKET SHARE OF CONTRACT RESEARCH COMPANIES, 2013 (%) 162
FIGURE 46 GLOBAL MARKET SHARE OF CONTRACT RESEARCH COMPANIES, 2013
(%) 162
CONTRACT PACKAGING 163
MARKET LEADERS 163
TABLE 60 SERVICES PROVIDED BY CONTRACT PACKAGING FIRMS 163
Market Share 164
TABLE 61 GLOBAL MARKET SHARE OF CONTRACT PACKAGING COMPANIES, 2013
(%) 164
FIGURE 47 GLOBAL MARKET SHARE OF CONTRACT PACKAGING COMPANIES, 2013
(%) 165
CHAPTER 10 PATENT ANALYSIS 167
PATENTS BY YEAR 167
TABLE 62 NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2013-JANUARY, 2015 167
FIGURE 48 NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2013 TO JANUARY 2015 167
PATENTS BY COMPANY 168
TABLE 63 NUMBER OF U.S. PATENTS BY COMPANY, JANUARY, 2013-JANUARY, 2015 168
PATENTS BY COUNTRY 169
TABLE 64 NUMBER OF U.S. PATENTS BY COUNTRY, 2013-JANUARY, 2015 169
FIGURE 49 NUMBER OF U.S. PATENTS BY COUNTRY, 2013 TO JANUARY 2015 170
TABLE 65 PATENT SHARES BY COUNTRY, 2013-JANUARY 2015 (%) 170
FIGURE 50 PATENT SHARES BY COUNTRY, 2013 TO JANUARY 2015 (%) 171
PATENTS BY EMPHASIS 171
TABLE 66 PATENTS BY EMPHASIS, 2013-JANUARY, 2015 (NO. OF PATENTS) 171
FIGURE 51 PATENTS BY EMPHASIS, 2013 TO JANUARY 2015 (NO. OF PATENTS) 172
PATENTS BY ASSIGNEE 172
TABLE 67 NUMBER OF PATENTS BY ASSIGNEE, 2013-JANUARY, 2015 172
FIGURE 52 NUMBER OF PATENTS BY ASSIGNEE, 2013 TO JANUARY 2015 172
CHAPTER 11 CURRENT SITUATION 175
FACTORS AFFECTING THE OUTSOURCING MARKET 175
COST SAVINGS 175
DECREASING RandD SUCCESS RATES AND MOUNTING DRUG DEVELOPMENT
COSTS 175
INCREASING DEMAND FOR BIOSIMILARS 176
INCREASING BURDEN FROM DISEASE 176
PATENT CLIFF 177
TABLE 68 SIGNIFICANT PATENT EXPIRIES OF BIOLOGICS 178
ACCESS TO CAPABILITIES/STATE-OF-THE-ART TECHNOLOGIES 178
PHARMACEUTICAL OUTSOURCING TRENDS 178
CHAPTER 12 COMPANY PROFILES 182
3M COMPANY 182
AAIPHARMA SERVICES CORP. 182
ABBVIE CONTRACT MANUFACTURING 183
AENOVA HOLDING GMBH 183
AEROGEN LTD. 184
AJINOMOTO ALTHEA TECHNOLOGIES INC. 185
ALBANY MOLECULAR RESEARCH INC. (AMRI) 185
ALKERMES PLC 186
AMCOR LTD. 187
AMERISOURCEBERGEN CORP. 188
AMPAC FINE CHEMICALS LLC 188
APTIV SOLUTIONS 189
APTUIT INC. 189
ARADIGM CORP. 190
BAXTER INTERNATIONAL 190
BCM/BOOTS MANUFACTURING 191
BOEHRINGER INGELHEIM 192
CAMBREX CORP. 192
CANGENE CORPORATION (NOW EMERGENT BIOSOLUTIONS) 193
CATALENT PHARMA SOLUTIONS 193
CEDARBURG HAUSER PHARMACEUTICALS INC. 194
CENEXI 194
CHARLES RIVER LABORATORIES 195
CHEMBRIDGE CORP. 195
CONFAB LABORATORIES 196
CONTRACT PHARMACEUTICALS LTD. 196
CORDEN PHARMA SWITZERLAND LLC 197
COVANCE INC. 197
DECODE GENETICS 198
DISHMAN PHARMACEUTICALS AND CHEMICALS LTD. 198
DPT LABORATORIES INC. 199
DR. REDDY'S LABORATORIES 199
DSM PHARMACEUTICAL PRODUCTS INC. 200
EVOTEC AG 200
FUJIFILM DIOSYNTH BIOTECHNOLOGY 201
GIRINDUS AG 201
GLAXOSMITHKLINE 202
GRIFOLS INTERNATIONAL S.A. 202
HERON THERAPEUTICS, INC. 203
HOSPIRA 203
HOVIONE S.A 204
ICON PLC 204
INC RESEARCH, INC. 205
JUBILANT LIFE SCIENCES LTD. 205
KP PHARMACEUTICAL TECHNOLOGY INC. 206
LIGAND PHARMACEUTICALS, INC. 206
LONZA GROUP LTD 207
LYNE LABORATORIES INC. 208
MALLINCKRODT PHARMACEUTICALS 208
MEADWESTVACO CORP. 209
MIKART INC 209
NEXTPHARMA TECHNOLOGIES 210
NORWICH PHARMA SERVICES 210
NOVAVAX, INC. 211
PACKAGING COORDINATORS INC. 212
PAREXEL INTERNATIONAL CORP. 212
PATHEON INC. 213
PERRIGO COMPANY PLC 213
PFIZER CENTRESOURCE 214
PIRAMAL ENTERPRISES LTD. 214
PPD (PHARMACEUTIAL PRODUCT DEVELOPMENT LLC) 215
PRA HEALTH SCIENCES 215
QUINTILES 216
RANBAXY LABORATORIES LTD. 216
RECIPHARM AB 217
REGIS TECHNOLOGIES INC. 217
SCHOTT PHARMACEUTICAL PACKAGING 218
SKYEPHARMA PLC 218
TAKEDA PHARMACEUTICALS 219
THEOREM CLINICAL RESEARCH INC. 219
VALEANT PHARMACEUTICALS INTERNATIONAL INC. 220
VETTER PHARMA INTERNATIONAL GMBH 220
WOCKHARDT LTD. 221
WUXI APP TEC 221
ZACH SYSTEM S.P.A 222
CHAPTER 13 APPENDIX 224
ABBREVIATIONS 224

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Printing Ink Markets in the World to 2019 - Market Size, Development, and Forecasts

Printing Ink Markets in the World to 2019 - Market Size, Development, and Forecasts

  • $ 24 725
  • Industry report
  • May 2015
  • by Global Research & Data Services Oy

The expansion of the global printing ink industry is forecast to reach 0.7% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 3.9%. Currently, black ...

Paint and Varnish Markets in the World to 2019 - Market Size, Development, and Forecasts

Paint and Varnish Markets in the World to 2019 - Market Size, Development, and Forecasts

  • $ 24 725
  • Industry report
  • April 2015
  • by Global Research & Data Services Oy

The expansion of the global paint and varnish industry is forecast to reach 1.8% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 4.8%. Currently, vinyl ...

Global Opportunities Derived from Glyphosate Industry

Global Opportunities Derived from Glyphosate Industry

  • $ 22 680
  • Industry report
  • June 2015
  • by CCM International Limited

This report is a value chain analysis of glyphosate’s upstream industries whose development and opportunities are driven or influenced by glyphosate industry. The whole report is an integrated analysis ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.